Nicox (FRA:NXOA) Total Assets : €49.55 Mil (As of Jun. 2024)

View and export this data going back to . Start your Free Trial

What is Nicox Total Assets?

Nicox's Total Assets for the quarter that ended in Jun. 2024 was €49.55 Mil.

During the past 12 months, Nicox's average Total Assets Growth Rate was -33.80% per year. During the past 3 years, the average Total Assets Growth Rate was -24.00% per year. During the past 5 years, the average Total Assets Growth Rate was -20.40% per year. During the past 10 years, the average Total Assets Growth Rate was -0.20% per year.

During the past 13 years, Nicox's highest 3-Year average Total Assets Growth Rate was 252.70%. The lowest was -56.80%. And the median was -3.50%.

Total Assets is connected with ROA %. Nicox's annualized ROA % for the quarter that ended in Jun. 2024 was -16.69%. Total Assets is also linked to Revenue through Asset Turnover. Nicox's Asset Turnover for the quarter that ended in Jun. 2024 was 0.12.

Nicox Total Assets Historical Data

The historical data trend for Nicox's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nicox Total Assets Chart

Nicox Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Assets

Get a 7-Day Free Trial

142.81

142.27

114.61

75.84

52.98

Nicox Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Total Assets	Get a 7-Day Free Trial															99.24	75.84	82.28	52.98	49.55

Nicox Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

Nicox's Total Assets for the fiscal year that ended in Dec. 2023 is calculated as

Total Assets	=	Total Equity (A: Dec. 2023 )	+	Total Liabilities (A: Dec. 2023 )
	=	21.413	+	31.567
	=	52.98

Nicox's Total Assets for the quarter that ended in Jun. 2024 is calculated as

Total Assets	=	Total Equity (Q: Jun. 2024 )	+	Total Liabilities (Q: Jun. 2024 )
	=	19.988	+	29.561
	=	49.55

Nicox (FRA:NXOA) Total Assets Explanation

Total Assets is connected with ROA %.

Nicox's annualized ROA % for the quarter that ended in Jun. 2024 is

ROA %	=	Net Income (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
	=	-8.554	/	( (52.98	+	49.549)	/ 2 )
	=	-8.554	/	51.2645
	=	-16.69 %

Note: The Net Income data used here is two times the semi-annual (Jun. 2024) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

Nicox's Asset Turnover for the quarter that ended in Jun. 2024 is

	Asset Turnover
=	Revenue (Q: Jun. 2024 )	/	( (Total Assets (Q: Dec. 2023 )	+	Total Assets (Q: Jun. 2024 ))	/ count )
=	6.069	/	( (52.98	+	49.549)	/ 2 )
=	6.069	/	51.2645
=	0.12

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

Nicox Total Assets Related Terms

Thank you for viewing the detailed overview of Nicox's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Nicox Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Nicox SA (FRA:NXOA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

NICXF:USA 0RCQ:UK ALCOX:France NXOA:Germany

Address

Rue Evariste Galois, Emerald Square, Batiment C, Sundesk Sophia Antipolis, Biot, FRA, 06410

Website

https://www.nicox.com

Nicox SA is an international ophthalmology company developing innovative solutions to help maintain vision and improve ocular health. Its lead program in clinical development is NCX 470 (bimatoprost grenod), a novel nitric oxide-donating bimatoprost eye drop, for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company also has a preclinical research program on NCX 1728, a nitric oxide-donating phosphodiesterase-5 inhibitor, with Glaukos. Its first product, VYZULTA in glaucoma, licensed exclusively worldwide to Bausch + Lomb, is available commercially in the U.S. and over 15 other territories. Nicox generates revenue from ZERVIATE in allergic conjunctivitis, licensed in multiple geographies.

Nicox Headlines

No Headlines